Læknaneminn


Læknaneminn - 01.04.1996, Qupperneq 51

Læknaneminn - 01.04.1996, Qupperneq 51
Lyfjameðferð gegn sýkingu af völdum alnæmisveiru - ný viðhorf AIDS in advanced HIV immunodeficiency with Ritonav- ir. 3rd Conference on Retroviruses and Opportunistic In- fections, Jan 28 - Feb 2, 1996, Washington, DC. 32. Kitchen VS et al Safety and activity of saquinavir in HIV infection. Lancet 1995; 345: 952. 33. Markowitz M et al. A preliminary study of ritonavir, an in- hibitor of HlV-protease, to treat HIV-1 infection. N Engl J Med 1995; 333:1534. 34. Mathez D et al. Ritonavir, AZT, DDC, as a triple comb- ination in AIDS patients. 3rd Conference on Retroviruses and Opportunistic Infections, Jan 28 - Feb 2, 1996, Was- hington, DC. 35. Massari F et al. A Phase II Open-label, randomized study of the triple combination of indinavir, zidovudine(ZDV) and didanosine (DDI) versus indinavir alone and Zidovu- dine/Didanosine in antiretroviral naive patients. 3rd Con- ference on Retroviruses and Opportunistic Infections, Jan 28 - Feb 2, 1996, Washington, DC. 36. Gukick R et al. Potent and sustained antiretroviral activity of indinavir (IDV) in combination with zidovudine (ZDV) and lamivudine (3TC). 3rd Conference on Retroviruses and Oppportunistic Infections, Jan 28 - Feb 2, 1996, Washington, DC. 37. Katlama C et al.Stavudine (D4T) in HIV infected patients with Cd4>350 mm3: results of a double blind randomized placebo controlled study. 3rd Conference on Retroviruses and Opportunistic Infections, Jan 28 - Feb 2, 1996, Was- hington, DC. 38. Markowits M et al. Triple therapy with AZT, 3TC and ritonavir in 12 subjects newly infected with HIV-1. (Abstract, suppl. Th.B.933). XI International Conference on AIDS, Vancouver, July 7-12, 1996. 39. Duncan IB et al Reduced HIV sensitivity during treat- ment with the proteinase inhibitor saquinavir. 3rd Confer- ence on Retroviruses and Opportunistic Infections, Jan 28 - Feb 2, 1996, Washington, DC. 40. Perelson AS et al. How Iong should treatment be given if we had an antiretroviral regiem that completely blocks HIV replication. (Abstract, suppl. Th.B.930). XI International Conference on AIDS, Vancouver, July 7-12, 1996. LÆKNAIMEMIIMN 45 1. tbl. 1996, 49. árg.
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100
Qupperneq 101
Qupperneq 102
Qupperneq 103
Qupperneq 104
Qupperneq 105
Qupperneq 106
Qupperneq 107
Qupperneq 108
Qupperneq 109
Qupperneq 110
Qupperneq 111
Qupperneq 112
Qupperneq 113
Qupperneq 114
Qupperneq 115
Qupperneq 116

x

Læknaneminn

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknaneminn
https://timarit.is/publication/1885

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.